-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 K6eZSFDaRaZ3DE6em+itqgwAg+DELEPpD86l/OUJQd3atZNNAi5h08g5TLq7/O4S
 iRDVE0hG204X/cfeEmIqiA==

<SEC-DOCUMENT>0000950123-08-004338.txt : 20080825
<SEC-HEADER>0000950123-08-004338.hdr.sgml : 20080825
<ACCEPTANCE-DATETIME>20080418140330
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0000950123-08-004338
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20080418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		140 WICKS RD
		STREET 2:		NORTH RYDE
		CITY:			NEW SOUTH WALES 2113
		STATE:			C3
		ZIP:			2113
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		107 NORTH RYDE
		CITY:			SYDNEY
		STATE:			C3
		ZIP:			1670
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
<TITLE>LETTER TO THE SEC</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="right" style="font-size: 10pt; margin-top: 12pt"><IMG src="y55037cry5503701.gif" alt="(COMPANY LOGO)">
</DIV>

<DIV align="left" style="font-size: 10pt; margin-left: 50%; margin-top: 6pt">April&nbsp;18, 2008
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><U>VIA EDGAR</U>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">United States Securities and Exchange Commission<BR>
100 F Street, N.W.<BR>
Washington, D.C. 20549

</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left">Re:</TD>
    <TD>&nbsp;</TD>
    <TD>Novogen Limited</TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Ladies and Gentlemen:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Novogen
Limited (the &#147;Company&#148;) is in receipt of the comment
letter, dated April 11, 2008,
from the staff (the &#147;Staff&#146;) of the U.S. Securities and Exchange Commission (the &#147;SEC&#148;) with
respect to the Company&#146;s Annual Report on Form 20-F for the fiscal year ended June&nbsp;30, 2007 (File
No.&nbsp;0-29962).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company will submit its written response to the comments raised by the Staff in the letter
to the SEC via EDGAR no later than Friday, May&nbsp;2, 2008.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="48%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="46%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="bottom" align="left">NOVOGEN LIMITED</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">By:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">/s/ David Seaton</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">David Seaton</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="bottom">Chief Financial Officer</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="left" style="font-size: 9pt; margin-top: 6pt">Novogen limited ABN 37 063 259 754&nbsp;&nbsp;&nbsp;&nbsp;140 Wicks Road, North Ryde NSW 2113, Australia&nbsp;&nbsp;&nbsp;&nbsp;Telephone &#043;61 2
9878 0088 Facsimile &#043;61 2 9878 0055<br> novogen@novogen.com www.novogen.com
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>y55037cry5503701.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 y55037cry5503701.gif
M1TE&.#EAG``^`/<``"$I*2DI*4)"0D*$>T*$A$*,A$I*2DIC8TIS<TJ$A$J$
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M]_?_]___]^____?______RP`````G``^```(_@#_"1Q(L*#!@P@3*ES(L*'#
MAQ`C2IQXL-X_BQ0S:MS(L2/$>A@]BAQ)LB3#>L1"FES)LF5&#2YCRIR)L%X`
M?_7X^<O'CZ;/GR)Q!J!C<5\^H$B33L19X8`_>__\[5-*M:K">D^,W-EG#Y\_
MJV##<O4RX0@??/^F_CL:MBU0KG<F%#AR[JB]KV[S^JQWAX&0(@[H]5RKM[#+
MIWR*`"D2(0F?M&P-5SW*4ZW!??YZLL4K\.C7P5,'1WVZS0B0"$$F#/EBSY[1
MJ`CW]>2\.;/`GK,Y*Y2*&3=LO)$'3LU,_#?!?5/S]<LLFJ!4G98;-B=<<"?U
MA"`=``$R(0$#"WG2_EY/&!GX^,X"=9.?3AEA>\)L@Q-D&]W@='_F#Y8_N--S
M^O1?4>:/$0PDD$`!"41@1![6D0>;<_GXAU>`^>#'T'L!$I;?0.UU.%Z%:QU5
M'X?H"6?A;@#*]YN%+/:&EC]8$)```0,DH)H1YYQ7W3]0$:33:*.=^.!"7^%W
M8I'J%6F<DDF^IMZ.!?'C)']/59D<A_OTHT\]7/'#$TC(">=%$`R4Z5T!$GB!
M#S\J$>05FP/EM(\^^,CVE)S]]%./BK>MB<]R4OW#3YV8]7-7@[-AIJ@^1F*V
M%C_]1%4/HSK^AA9!V<C33E?\X:-I.B#VN):1]JB3S3##+&.-.JU-9=$?_A$D
M`(009R9@033XM#G04^V(QE-:]=C3#C35L)I.H'P>9Y2PZC3;&I>>0?65/6Q6
MVVIK/.+5SZ;R',JGE]@2E(8889BBJT#U@#+&&NU<9%`]W92R1A@ZS*"##FM\
M4@U4/-&#Q`1`D"FCC4O@A)`]FL1!2WK\M%;-*G#H$$888N1+33YW8<>C-;I(
MLH888HR1!B2>*-.N=3T=8XDEF$!2AR608(+)')@,$^<L+6M23:7US++)+"KI
MX$(*8>QLT%-SQ!!&NRK5@\\J9]!0@PTV#.(""C70H,,L.W&)1:QR$8#:=UY,
M-Q`WA_#0C'#QC!+&"310374-,("A"3LCHOL/_CJCC#&#"V384`,*9*1P`@]V
M'!O9+(/7X/CC9:1`QBL#V1.*U"G,T<Z3/,9!AAS-Q0!#"3`L$L]RHO((20R(
MW),/9OG4R<\G*,!PPQNKU(),+:O$0<,@--S"SSWUX&$!`PJ`'40$$R`Q3T]%
M':7/*S7$(<^@]7`#"0LNS)"&)[30$LH;,ZP@0QD[Z_1ZA?KLH\P/+<0PPQIV
MB#+**)F\(;D<['R%D2XQ*($<[!`S2;0,$Y^P66=*$0.LU2`5D;K+:]*2"!M,
MHB`-Y`'I@*:;UZWN#/J(D%&\,@P=H$`'M_!&5QIF#W:4P@PGM)D_SF&$!21(
M5@"S4=FBPI.G[,,1_C581</JT8XX@``&8DBA/>+1FG;H0@P@J,$8FO&Z-;W.
M'L'P00ENX`A>J+`U2[2'-4+AB]>-BA\`W`$VJ)43,.:$(*2H00SDR`9KH$5:
M/;$'(VH0B4L))`8MX$0:8I`&;`B)1XXH0>L&E1E\J.,-M=N%/7*"D\SDA!<T
M("0W!)*%"4Q`1@7RCH*"%14)6F,')U!'/9Z"B1*D``W->$I:,H,Q<JRA!"Z0
M@SJ&PY5F1)$&=;#&)'4B)2WY0Q\GXU%4`,@#0TJE'UG"C&Y*(4='T*`%D8"-
M?_C!B!A,0B4QB`$O>C&#&F#"'O?PT>I:AS'8,#`&KU@3?KR"GRS9XQ(M_BB!
M)_)1#VE8H#L$,%.!)("'%]E#3Z=(@2-6N8]AT"`0,`B&-.EAI*_0(QL["`0-
M5N&N?F1C$3)`P1O4(26<*.H?^.`79C*6CS1ZPRB4><\"!:<,2U!-%_Y(:9P2
M48-)A`X&PH@'*+(6BAZBU!X?W,<=_9&.,+3`#4Z;3WHJY(QKSL"._,!`!`90
M(`8`H4!`>`(]E,G4-L2`H_U@!QQ0(`-2[&.5)$J//1AG@C3L\G6DX,$(V+!)
M)0G$'A$:%7"^DL9L[.2PL4/IKE(A1V20XPTQ.,,PWG0;-M3@$1@$*E?>L`,:
M\,*,JF.=H2I4#UW`(`:EH&A<[9)33*``!:7@_@H]+A`!L((R"!;@@R7_,8L2
M@,`:.;4&#%!@!GE8,:[*K,<::L>+G*I###*@P2PJQ"<C#2DMNK`!#UY:46ER
M9A^,K0$R]E$--!"7&VKA"1MB\`C=Q,`&S;4'-79@@S:L0ZY`1$0(S4B[&-3B
MK0*Q$VSNDH]9P*`%=>"*/?(``2`8:$81^&H6BF2/.,3`#6_UQRU0$(-S/J<G
MLA&/3O#QB1&4X!.8248)6!`&;ESJ5T4J:4@:-(LY8J.-;'IK=/"1"A[4X!DA
M/(7HA`@;?E@6LP29XS".4H]2@*`%H8#6#V-@AGO<I2N8:`$(FH&/7QE'4%]9
M!AA"\`;H^:,"L9J1_H%BM020U,,:(+"!*"AJCT_(``:G6$N(Q2.HB^1#'Z9%
M@25`HHL4B+1_HII-GV;CI:_@@Q<V0,$E-H$*3F2"$Y^X1;N$P]@8Q)*?8JA!
M&]2!4MFL]Q'!$=TPOK*/=-3!!64PQK(L;`:T6`0?D&@!#*H!(H1\!1LF9`1:
M>D(,"D18`0826Q'0\111."X=4<'')L+Y"NMPSBCZ4`8@ZW"758CN#90UR*'D
M$:",^0.`,J!;XV)`@SFD+A^?D..G^<&,,,3@%,2,1R)H0(F"R''5?U5&&&PP
MTITXH@5FV)/_)($"M7'NK_BI!@A64&8-Y0$!$78P`8!@@3X\)0T*S1:)_AON
MB@$?!-O)B($,0+>/5:1@!'&(D-G$DPYOJ'`GP]$%"D;@"#G$H0Z0B`,F8N&H
M]'3:&D9A$RB0>`P>&=F;!>%!#`!.&4]$^A53@4,+RM`/T'HB!?`-E*_W85H5
M0$(T]J`''RQPO*\6(0AWJ,<Q:)`"7NS*%"']1#V6XQY_]$,5U\2$5'[A`AB,
MP<4U^8?;U%`-J;SH%3'@P3.H!<;6Z,8?J<":,W;"#WVHPPP=#I8]V`"#"Q+D
MWP$:5#I\4(@P6(,?6F>#PKO-`QN<HN@&(2TH4-`"4,"81_6@`P(8$(0@%*$(
M6$A7",KP1J_PPG%OL`>C^+3*>F0"!BEXQ2J7_L&#%-#`%^$^3CY"48:BB=T?
MU+M!-H;#9S^F)14EJ,'F>UB/4Q1^%E)"!!]UPP,8*(.6L,$+M8=O:Q4&\F01
MU1`&-+!0,_<HZJ`#<]1T!'$7]7`!$%`$GE0$2]`.:8`"GA`=W!!J.]`,<(40
M^(!1,'`"U:`3[:`_)B`':><NU6$*@M-XZG-NHG,L`O%BU^$/GS!'L<0C%6(-
M9F`#:R`/Z7!DNH%ZZ.$/\5`'-&`&S[!6M09:]C`'.R!_R7(1O[`#*9`&@+4K
M7L(/T:`$#\`80:`$ND`#,$""P,$/F$`WF,!/!^,/I"`ZM>8E_W`+(.`"TB4J
M*I$/#%0#AF1ND+<#_NK00262%I^0`C&`=()B1JK``S30"?:`"#20"4L(`ZM&
M+7V&#T2(`I^@""@@>Q4R*/_`"SI@`X-F@O8`22G`-<[193S2!TAP/$5@`6/P
M5$HU6,<P.#/P"[T6)7,73CBU)_L0#XX`2&%P#)P2):(P1\!%8!H6`SO@#>I!
M+9SA@]+(>7>14F^@7;R`"*6G&SO`B6K1(ZMT"VS80&Q0)VP1+)]@`Q\`"H`%
M5_VA#J5``R$@">U@*+L2)_40#0T``41P!!V``K<00@/V%)\0?V(P#-(R3VOA
M#&;0`C#7#A9Q%_S0#&+`86$@#*YA'=05"J?5>.:F<SOP#4TH(H0Q*#\(_@-V
M%!IHL0_-0$<@$`.:2!`P@([!\17MD#188P8$9AGL4`>UEP:ET`S6@(3',`JW
M!`.8@#?711`@H0>WN``>8`;D@'OIP0Z@<(X[4`?`H`[I4`_JD`QVX`..8PF;
M-(S\8`V/<%HU``FK,`WQ\%;V0`Z8('6&9!1?`7DZT`SQT`Z%V2VLLB?N$F\Q
ML#,-4DJKX(7#!0GNEP(MH`SU<6O+,#4I\`94>49ZP@ETTY,[L`/]QVX@4`J`
M91L5X6:V:`$<$%L9`R'V,`QF0`/GB`,_\`,[(#HPD`:ZT!HN&2?V\$0\P'LQ
MH`,_P)8]&0@Z8`W],!OY<`LL(`([H`.EF9T\_F`&G8`1388"-F`-PY@M"',"
M,>`"IC<09F`&Q]`F9M0.EF`O:K!*7G94^7`,EW"=<3,U=?D+Y!9MB0<2^9`%
M%[`!2!>(CM)EWE`*;:`#_9>;/$`*K\>0,EAJ3J@.HK`&.E`#@3`(@=`"-@`#
MA^`)J]0C_K`*QQEY-9!N<C0U=<`3:`$*.D`#T!:(=<(-9C`#-*`)P=$:/R)5
M^"$/UH`-V8`1?N09AN(-RS`+LQ`+PZ`.UT-/#U<0%>($5S";.X(7]B`/S;`*
MH!`*J[`,K-)K*J(<HV(/QB`*G^`)I0`*M#`-I*0;]3`-QW`,P]`,QX"G=GH,
MW#`8^:`.PW`,U=5U_LL0"IY0"P71/OI0*<]1);*T*]H2(!913];E$!9!#Y.J
M(TCB#V/E9SLH%8])I10"()B!%GDB+3OB&?A1(1;B&;T"8`C1=6`TGJ#:=P/Q
M)C\9(*`*4ZOI5UMHE>X2JK0!($52(=+D'%%"'>WD'Q$2AE(5(A$2K=+J9812
ME7T&'2BEA_.AK0$)K<S*&9[XDIV''*]1G[^:%EQ1K.K!%OQR$>'J=*JZB)](
MK@W39[SA*WB!'(Q248V2>J"*I<(!%0<U%>XG&09[L`B;L`J[L`S;L`[[L&YA
M$>>2$1,+L2Y1L5:)L11;$!IKL1M[$A([$A7;L7GAG>Y2GR$1LBDK@]`B_GWV
MH`<&4THL^Q1;,*EAZ"K`:K(@@2[#Y@]ZP`XL6P]Z<*YZL;/HX"Z3Y&87(;%N
MUK1,^[1S^@?R,`]-N[1[L[3UT`7(R`Y=L;-*"[4J*[%;\%9>ZV93@`XDZQ8:
MH`%$P;;2X`]74`_PL`?\1`<8P`3$H`%=@`Y6H`$IP00P40%T0`=2,`]-@`7A
MX`=]H`%-0`]=P`1X<!=[(`4:@`Y,T`0:4`^+JP=XP`1TT`160+G!QP1Z8+G2
ML`5,(`UX@+;;8`!7$+=7P`3_H`%7*@5;D+D+6P^92P=34#Q2L`]:T`1[X&8:
M8`^D6P]-$`U<H+M,4`][(`V52P_:\`7%\`?N_N`'5."\=+"\<5L/5Y`24E`!
MFGL.(#&YZ:`!])"Y4N!F3+"^];"^[?L/TK`-F=N\7?`/Z8`/3?"^>-"PWNN\
M&G"Y>"`.4Z`'5B"Q^SL%%:`!%1`-XE`/4\"X?MN\4Q`%U/L'X.`'>@`2&:`'
M^*"U_R`%QX*Y]B`-T6"W4S"\3&`/3<"WY[NVPUL/%,`$4["^VQ`-^\L$TW"_
M>*`!`H"\>(`!J7.P];`%_[`'^WL1%0`/5E"S^\`.ZRL%D3N0#]RW[%L/5M`'
M7T`,?U`,V.N\>]`']G`%%W$%TF"\LBL-?5"S>;`'_]"\S2L%Z+"^`9QV(FP/
MF7L%VT#'65L/S9O'UOWDQ@HKM/D@#7[<MOY`#%8`%<''P'O`!'M+OG2`#FM;
MQ!`\!7Y`#EZ`#'[`!XQ+#V^[P>_;!"U<LRB!NGA@R$2AM6W;!&:,`7.L`=(P
M#A@@!>P0#5(0MU/0!#U<`?]`N+B[L&NRL^X2+/`(8%/,3_SD9A3X#_'@-).2
M=C@!)FL!$E)`#TD++%U&2G[&%?!XM&?IKKFR2NQ0MB%[EFO2L'ZDL@2Q!5)`
M#%$Q&!CA*P#F&NL3'1@QM'(ELW@1L@$;(&H1$NE\7/ZC-QZK,6E[T!";T`T;
$$```.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
